Was Merck's HIV-producing "vaccine" technology a forerunner to vaccines producing viruses today?

One of the theories I have about the Vaxdemic is that COVID "viruses" can be created by “vaccines” through a recombinant process. Are they?

Today the public accepts that the "vaccines" create a part, but only a part (do you trust them?) of the Sars-CoV-2 virus, the "spike protein. " The spike protein was in turn a bioweapon inserted into coronaviruses along the way, which made it more infectious than a natural substance. The public doesn't think that the pharma companies would just give you the whole virus in an disguised effort to protect you from getting the whole virus. Nah, they would never do anything like that, would they? Meanwhile the public has no knowledge of the actual computer-generated mRNA sequences in the vaccines and pharma can generate anything they want in your body with mRNA without any oversight and you know that they’ve lied to you about everything else, so consider this.

Varying the mRNA code slightly could produce different "variants" of the virus. "Variants" exploded after vaccinations began.

Many people, including Robert Malone, describe the process whereby "variants" are created as some version of ADE, antibody-dependent enhancement. Malone, a DoD expert on disinformation, has many times spoken about enhancement, as reported by COVID call to Humanity:

"The government seems to be obfuscating what is happening here. ... The escape mutants that are escaping vaccine selecting pressure are most likely developing in the people that have been vaccinated, not in the unvaccinated, so that’s just another convenient lie."

I haven't heard Malone say that you can get the entire "virus" sequence is through a "recombinant" process. I don't know if that happened with COVID, but I’m pretty sure it happened with HIV and Merck using Malone's patented "naked DNA technology." Let's take a look at it. First some background, because we’re going back pretty far to get to the origins of Merck’s HIV creation in humans. So far that when Malone acts ignorant about the origins of what is happening today that I call bullshit.

Merck was a student at the Salk Institute where he developed many of his theories. The Salk Institute was named after Jonas Salk. Malone refers to it as the "Temple of Vaccines." Salk was credited with developing the polio vaccine that saved the world from polio. It was a lie. Polio was not caused by a virus. It was caused by lead, arsenic, and DDT. They started banning these neurotoxin poisons as they rolled out the “vaccine,” and then defined “polio” as a host of other diseases.

Polio was not caused by a Virus, nor cured by a Vaccine

1986-1989. Malone: While I was there (Salk Institute), I was a graduate student in an incredibly competitive post-doc lab. You know all normal ethics are suspended in that kind of environment. Much as we see with Tony Fauci and some of his operations.

Robert Malone left the Salk Institute after what he called a "nervous breakdown" and took his RNA/DNA "technology" to Vical in 1989.

Malone: And they (Vical) set up a skunkworks for me. And that's what led to the discoveries called naked RNA and naked DNA and this set of 9 patents that were all filed in 1989 that describe the logic and demonstration, in other words reduction to practice...

Merck began financing Vical's research in 1991.

Nature: In 1991, Vical entered into a multimillion-dollar research collaboration and licensing pact with US firm Merck, one of the world’s largest vaccine developers. Pharma intelligence: The vaccines will incorporate Vical's Gene Therapeutics technology, in which gene sequences from viruses are used to stimulate the production of antibodies."

In March 1993, the New York Times reported how Merck intended to use the "technology" to inject DNA particles into humans to generate antibodies against the poisons. The difference is that the "naked DNA" technology caused the cells of the mammals to generate the poison that the body would in turn create a defense against with antibodies. Note here that a principle of the thousands year old satanism (disinformation) is to get everything exactly backwards, such as taking a poison to prevent being poisoned.

A NEW kind of vaccine, which uses direct injections of DNA particles instead of the whole virus to induce immunity, has proved effective in protecting mice against influenza A. The new method delivers "naked" DNA directly into a cell, prompting the mice to manufacture foreign proteins and then antibodies against them, holding out promise for vaccination against other infectious diseases, scientists reported recently in the journal Science. Immunization with DNA mimics an actual infection more closely than a traditional vaccine does. With a traditional vaccine, an artificial virus protein, or antigen, acts as a stimulus for antibody production. But with a DNA vaccine, the virus protein is made in the cell rather than in the laboratory.

On May 4, 1994, Merck and Vical expanded their "naked DNA" partnership. They first began developing "vaccines" using the "technology" for hepatitis C and human papilloma virus. They expanded to hepatitis B and herpes. They planned to target HIV and influenza. University of Michigan:

VICAL~, News Release 9373 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA 92121 PHONE: (619) 453-9900 FAX: (619) 453-5885 FOR IMMEDIATE RELEASE May 4, 1994 Contacts: Martha J. Demski, Vice President and Chief Financial Officer Robert H. Zaugg, Ph.D., Vice President Business Development Vical Incorporated 619-453-9900 VICAL AND MERCK EXPAND NAKED DNA VACCINE AGREEMENT SAN DIEGO, CA - Vical Incorporated (Nasdaq:VICL) announced today that Merck & Co., Inc. (NYSE:MRK) has acquired an option to an exclusive license to use Vical's proprietary gene-based vaccine technology for development of a tuberculosis vaccine. In addition, Merck has exercised its options to license, under its 1991 Research Collaboration and License Agreement with Vical, the Vical technology for use with two vaccine targets, hepatitis C and human papilloma viruses. Merck has also extended its exclusive option to license the Vical technology for use with two other viral vaccine targets, hepatitis B and herpes simplex. Merck has paid Vical the sum of $2,300,000 in return for these license and option rights. Merck has chosen not to extend its option to license the Vical technology for measles. Merck's exercise of the two options for hepatitis C and papilloma brings to four the number of vaccine targets licensed under the existing agreement between Merck and Vical. The other two licensed vaccine targets are HIV (the cause of AIDS) and influenza. Under the agreement, Vical will receive milestone payments and royalties for licensed vaccine products that Merck develops.

In June 1994, shortly following the announcement of Merck and Vical to begin developing a HIV vaccine using "naked DNA," the government announced that they were scrapping plans to develop HIV vaccine using another technology. Jon Cohen, Science:

The momentum virtually halted in June 1994, when NIH declined to fund large-scale efficacy trials of vaccines made by Chiron and Genentech. Both vaccines were based on genetically engineered versions of HIV's surface protein, gp120. The hope was that these viral proteins would raise antibodies that would attach to the virus in the bloodstream, before it infected cells, but NIH got cold feet when test tube experiments showed that the antibodies these vaccines produced could only stop laboratory-grown strains of HIV--not ones freshly isolated from patients (Science, 24 June 1994, p. 1839)

On December 3, 1996, patent #5,580,859 was issued to Robert Malone for a Delivery of exogenous DNA sequences in a mammal. The December 3, 1996 screenshot below is from Robert Malone's curriculum vitae. I took a closer look at it.

Some language from Malone's patent #5,580,859:

The clinical application of gene therapy, as well as the utilization of recombinant retrovirus vectors, has been delayed because of safety considerations. Integration of exogenous DNA into the genome of a cell can cause DNA damage and possible genetic changes in the recipient cell that could predispose to malignancy.

He used the term "recombinant" 13 times. "Suitable template DNA for production of mRNA coding for a desired polypeptide may be prepared in accordance with standard recombinant DNA methodology," and so forth." I don't pretend to understand it all. I submit the implications I’ve stated for "peer review" here, and by peer review, I mean honest medical professionals with enough common sense to see past disinformation, not the type of "peers" that Robert Malone has associated with throughout his professional career, like the Gates Foundation, the Defense Threat Reduction (increase) Agency, and Merck (the world's oldest and most evil pharmaceutical company).

On December 31, 1996, patent #5,589,466 was quickly granted after the December 3, 1996 patent #5,580,85. Patent #5,589,466 was called Induction of a protective immune response in a mammal by injecting a DNA sequence. They called this patented method of poisoning a "therapy."

A method for delivering an isolated polynucleotide such as DNA or RNA, to the interior of a cell in a mammal comprising the injection of an isolated polynucleotide into a muscle of the mammal where the polynucleotide is taken up by the cells of the muscle and exerts a therapeutic effect on the mammal. 

In Fall 1997, Merck and Vical expanded their agreement once again using this technology, this time for HIV "vaccine." BioWorld:

The companies signed two deals within two months of each other in the fall of 1997. The first, valued at $35 million plus royalties, gave Merck the right to use Vical's technology to deliver genes encoding a small number of growth factors. The other, valued at $23 million plus royalties, was aimed at developing and marketing therapeutic vaccines against HIV and the hepatitis B virus. (See BioWorld Today, Nov. 6, 1997, and Sept. 16, 1997).

In December 1999, Merck began human trials of their HIV vaccine using "naked DNA" technology. From Motley Fool (stock) message boards (link no longer functions):

Merck is now developing vaccines based on Vical's naked DNA vaccine technology to prevent and treat HIV infections. Merck is testing naked DNA vaccines for HIV in two human trials, one for uninfected volunteers and one for volunteers already infected with HIV and receiving highly active anti-retroviral therapy. The human testing began in December 1999.

The trials went on for about 8 years, then they were stopped because they said they were "not effective." Fierce BioTech:

September 24, 2007. WHITEHOUSE STATION, N.J. & SEATTLE -- Vaccination in a phase II clinical trial of Merck & Co., Inc.'s investigational HIV vaccine (V520) is being discontinued because the vaccine was not effective. The announcement was made today by the co-sponsors of this clinical trial, Merck & Co., Inc., and the HIV Vaccine Trials Network (HVTN), which is funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health.

The Dominican: Dr. Anthony S. Fauci, the director of the National Institute of Allergy and Infectious Diseases, which conducted the trial with Merck, said in an interview that “the results are obviously disappointing.”

Disappointing? Not effective? Depends on how you look at it. What was the true goal of the trials?

Surprise surprise, they managed to increase the amount of HIV.

October 14, 2007. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Although HIV acquisition rates were similar in vaccine and placebo recipients with baseline Ad5 titers ≤18 (Ad5 seronegative participants), surprisingly, rates appeared to be more than twice as high in vaccines compared with placebo recipients in Ad5 strata >18, (overall HIV acquisition rate 5.1% vs. 2.3%/year, unadjusted two-tailed p-value 0.013). There was also evidence that the hazard ratio increased with increasing log10(Ad5) (univariate Cox model trend test p-value = .06).

More vax, more HIV. Do you really think people this smart failed this badly? That they created in humans exactly what they were funded to stop? I don't. Here's a suggestion. As Dr. Tess Lawrie did with all the small trials on Ivermectin, combining them into one big result to show unequivocally that Ivermectin was a safe and effective method to treat COVID, combine every study or trial of "vaccines" together, and see what it looks like. It appears that this billion dollar industry has never done anything but kill and cause disease in the human population, and they have never been punished for it. They pay a small fraction of their profits back to victims in the form of fines, but that's a cost of doing business, not a punishment. They should pay with their lives.

In November 2007, Jon Cohen wrote: Did Merck's Failed HIV Vaccine Cause Harm?

AIDS researchers, who are still staggering from the unexpected failure in September of the most promising vaccine candidate in clinical trials, met here last week to explore an even more alarming finding: The vaccine, made by Merck and Co., may actually have increased the risk of HIV infection in some study participants.

Working with the academic-based HIV Vaccine Trials Network (HVTN) and the U.S. National Institutes of Health (NIH) in Bethesda, Maryland, Merck researchers stopped the multicountry study after an interim analysis revealed that the vaccine did not work (Science, 5 October, p. 28). Now further analysis suggests that the vaccine may have helped HIV infect a subset of participants who at the trial's start had high levels of antibody to adenovirus 5 (Ad5), which causes the common cold and is also a component of the vaccine. 

Cohen looked at it like ADE here, and maybe that's a part of it. But as far as I'm concerned, if these people know enough to create little pieces of the "virus," they know enough to create the whole thing.

What they had done in this "vaccine trial" was to add 3 components of HIV to a common cold virus.

"The vaccine contains three HIV genes stitched into a modified Ad5 vector that infects cells, creating HIV proteins that teach the immune system how to attack the real AIDS virus."

Yeah, what a great idea. Take HIV to protect you from getting HIV. It worked great in mice, according to Malone, but it wasn't "scalable" to larger mammals. Bright Light News, November 9, 2022:

The DNA vaccines just never worked out.   Merck spent billions of dollars on the technology.  And it worked great in mice.   And they could never get it to work in larger animals or in humans for a variety of reasons.  With the exception of some platforms to some extent using pulse electrical fields.  But for the most part it just was never scalable.   

Robert Malone is just now beginning to be the subject of some research himself. You can take every line item in his CV and question it. I haven't looked closely at his involvement with Gates Foundation yet, but what do you think I'll find? I've went back to his start with the Salk Institute, and some of the implications are so bad that I think I need to build up to it like I'm doing here.

Joseph Mengele didn't get to write the history of his wonderful genetic research to benefit mankind, and I don't think Robert Malone should either.

Charles Wright